International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Institute of Constructors American Institute of Constructors The American Institute of Constructors (AIC), is a not-for-profit 501(c)(6) non-governmental professional association founded in 1971 for the advancement of professionalism and ethics in the Construction industry. Individuals involved in the AIC are typically found in the construction management Industry. The Institute is the constructor's counterpart of professional organizations found in architecture, engineering, law and other fields. As such, the Institute serves as the national qualifying body of professional constructor through its Constructor Certification Commission. The American Institute of Constructors exists to promote individual professionalism and excellence throughout the related fields of construction. AIC supports the